PAPER Wu YY, Delgado RM, Sunderland T, Csako G

Detection of a deletion polymorphism of the human alpha(2)-macroglobulin gene (A2M-2) by a semi-automated PCR-single-stranded conformational polymorphism method.

Clin Chem. 1999 Sep;45(9):1572-3. PubMed.

PAPER Yamauchi K, Tozuka M, Hidaka H, Hidaka E, Kondo Y, Katsuyama T

Characterization of apolipoprotein E-containing lipoproteins in cerebrospinal fluid: effect of phenotype on the distribution of apolipoprotein E.

Clin Chem. 1999 Sep;45(9):1431-8. PubMed.

PAPER Rahbar S, Kumar Yernini K, Scott S, Gonzales N, Lalezari I

Novel inhibitors of advanced glycation endproducts.

Biochem Biophys Res Commun. 1999 Sep 7;262(3):651-6. PubMed.

PAPER Van Nostrand WE, Porter M

Plasmin cleavage of the amyloid beta-protein: alteration of secondary structure and stimulation of tissue plasminogen activator activity.

Biochemistry. 1999 Aug 31;38(35):11570-6. PubMed.

PAPER Wolfe MS, De Los Angeles J, Miller DD, Xia W, Selkoe DJ

Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease.

Biochemistry. 1999 Aug 31;38(35):11223-30. PubMed.

PAPER Smith MZ, Nagy Z, Esiri MM

Cell cycle-related protein expression in vascular dementia and Alzheimer's disease.

Neurosci Lett. 1999 Aug 13;271(1):45-8. PubMed.

PAPER Fiebich BL, Hofer TJ, Lieb K, Huell M, Butcher RD, Schumann G, Schulze-Osthoff K, Bauer J

The non-steroidal anti-inflammatory drug tepoxalin inhibits interleukin-6 and alpha1-anti-chymotrypsin synthesis in astrocytes by preventing degradation of IkappaB-alpha.

Neuropharmacology. 1999 Sep;38(9):1325-33. PubMed.

PAPER Nauta HJ, Wehman JC, Koliatsos VE, Terrell MA, Chung K

Intraventricular infusion of nerve growth factor as the cause of sympathetic fiber sprouting in sensory ganglia.

J Neurosurg. 1999 Sep;91(3):447-53. PubMed.

PAPER Mavaddat N, Sahakian BJ, Hutchinson PJ, Kirkpatrick PJ

Cognition following subarachnoid hemorrhage from anterior communicating artery aneurysm: relation to timing of surgery.

J Neurosurg. 1999 Sep;91(3):402-7. PubMed.

PAPER Farrer M, Gwinn-Hardy K, Hutton M, Hardy J

The genetics of disorders with synuclein pathology and parkinsonism.

Hum Mol Genet. 1999;8(10):1901-5. PubMed.

PAPER Hillery A

Novel vaccine strategy demonstrates potential for Alzheimer's disease.

Pharm Sci Technolo Today. 1999 Sep;2(9):347-348. PubMed.

PAPER Raina AK, Monteiro MJ, McShea A, Smith MA

The role of cell cycle-mediated events in Alzheimer's disease.

Int J Exp Pathol. 1999 Apr;80(2):71-6. PubMed.

PAPER Young DG, Skibinski G, Mason JI, James K

The influence of age and gender on serum dehydroepiandrosterone sulphate (DHEA-S), IL-6, IL-6 soluble receptor (IL-6 sR) and transforming growth factor beta 1 (TGF-beta1) levels in normal healthy blood donors.

Clin Exp Immunol. 1999 Sep;117(3):476-81. PubMed.

PAPER Koo EH, Lansbury PT, Kelly JW

Amyloid diseases: abnormal protein aggregation in neurodegeneration.

Proc Natl Acad Sci U S A. 1999 Aug 31;96(18):9989-90. PubMed.

PAPER Gómez-Isla T, Growdon WB, McNamara MJ, Nochlin D, Bird TD, Arango JC, Lopera F, Kosik KS, Lantos PL, Cairns NJ, Hyman BT

The impact of different presenilin 1 andpresenilin 2 mutations on amyloid deposition, neurofibrillary changes and neuronal loss in the familial Alzheimer's disease brain: evidence for other phenotype-modifying factors.

Brain. 1999 Sep;122 ( Pt 9):1709-19. PubMed.